'DNA origami' tackles multidrug-resistant cancer cells

CATHARINE PADDOCK PHD | November 26, 2018

article image
A DNA tool that combines gene therapy with chemotherapy could be a promising new way to defeat multidrug-resistant cancer cells. The tool is a "tailored DNA nanoplatform" that can carry chemotherapy drugs into targeted cancer cells while also silencing the cells' drug-resistance genes. The technique is the work of scientists at the National Center for Nanoscience and Technology in Beijing, China. 

Spotlight

Alpha Adhesives & Sealants Ltd

Established in 1987 Alpha has become a worldwide supplier of quality Adhesives, Sealants & coatings that are manufactured at its UK base in Stourport on Severn, Worcestershire. In 2004 Alpha acquired the Industrial Adhesives Division of DUNLOP who's origins date back to the early 1900's and are synonymous with brand names such as thixofix. Alpha have the commitment and ability to develop and manufacture products for particular specialist applications and prides itself with offering customers a working partnership in order to achieve the best possible results together.

OTHER ARTICLES

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

Alpha Adhesives & Sealants Ltd

Established in 1987 Alpha has become a worldwide supplier of quality Adhesives, Sealants & coatings that are manufactured at its UK base in Stourport on Severn, Worcestershire. In 2004 Alpha acquired the Industrial Adhesives Division of DUNLOP who's origins date back to the early 1900's and are synonymous with brand names such as thixofix. Alpha have the commitment and ability to develop and manufacture products for particular specialist applications and prides itself with offering customers a working partnership in order to achieve the best possible results together.

Events